Recent news highlights NVE's year-over-year earnings growth driven by strong sales and new product introductions, positive analyst ratings, and detailed earnings call insights reflecting growth momentum and strategic focus on defense recovery and AIoT demand.

• NVE reported a year-over-year surge in Q1 earnings driven by strong sales and new products [N1].
• The Q1 2027 earnings call transcript and highlights provide insights into growth momentum and product developments [N2][N3].
• NVE earned an 'Outperform' rating based on defense recovery and AIoT demand [N4].
• The company reported solid year-over-year earnings growth in Q4 and unveiled a strong outlook [N5].
• Q4 2026 earnings call transcript offers detailed discussion of financial and operational performance [N6].
• Q3 2026 earnings rose 11% year-over-year, highlighting growth momentum [N7].
• Q3 2026 earnings call transcript provides additional context on company performance [N8].

NVE's advanced spintronics technology positions it well in growing markets like IIoT, AIoT, and medical devices, where demand for precise, reliable, and low-power sensors and couplers is increasing. The company's in-house manufacturing and quality certifications support product reliability and innovation. Its patent portfolio on MRAM and other spintronic devices could enable entry into emerging memory markets. Recent earnings growth and positive analyst ratings reflect market recognition of its technology and strategic positioning [N1][N4][N5].

NVE faces competition from alternative sensor technologies such as silicon Hall-effect and anisotropic magnetoresistive sensors, as well as from electromechanical switches in medical applications. The company depends on a few large customers and distributors, which could impact revenue if relationships change. Regulatory compliance costs and potential penalties pose operational risks. Market adoption of MRAM and other spintronic products may be slower than anticipated, and manufacturing reliance on foundry wafers and Asian packaging services introduces supply chain risks [S1].

NVE's moat is based on its proprietary spintronics technology, which offers advantages in size, sensitivity, precision, and power efficiency over competing sensor and coupler technologies. The company's in-house wafer fabrication and testing capabilities provide manufacturing control and quality advantages. Its extensive patent portfolio, including advanced MRAM designs, protects intellectual property. Established distributor relationships and private-brand partnerships expand market reach. The company's focus on specialized markets such as medical devices, IIoT, AIoT, and defense-related applications further differentiates its offerings [S1].

• Customer Concentration Risk: NVE relies on several large customers including Abbott Laboratories and distributors for a significant portion of revenue. Loss of one or more could materially affect financial performance [S1].
• Competitive Risk: Competing sensor and coupler technologies, including silicon Hall-effect sensors and electromechanical switches, may limit market share growth [S1].
• Regulatory and Compliance Risk: The company is subject to extensive government regulations and may incur costs or penalties related to environmental, safety, and export controls [S1].
• Supply Chain and Manufacturing Risk: Dependence on foundry wafers and packaging services in Asia could expose NVE to supply chain disruptions [S1].

• NVE Corporation develops and sells spintronic devices that use electron spin to acquire, store, and transmit information, including sensors, couplers, and MRAM products [S1].
• The company is headquartered in Minnesota and was founded in 1989 by a spintronics pioneer [S1].
• NVE's spintronic products include magnetic sensors (standard and custom), couplers, power products, and MRAM memory devices [S1].
• Spintronic sensors detect magnetic fields for position, speed, and rotation applications, with markets in Industrial Internet of Things (IIoT) and Artificial Intelligence of Things (AIoT) for factory automation [S1].
• Custom sensors are designed for medical devices, replacing electromechanical magnetic switches, offering advantages in size, sensitivity, precision, and reliability [S1].
• Couplers electrically isolate systems and transmit data using spintronic sensor elements combined with microscopic coils, targeting power conversion, IIoT, and AIoT markets [S1].
• Power products include voltage regulators, interface ICs, DC-to-DC converters, and combined coupler-converter products used in energy conversion systems and industrial networks [S1].
• MRAM products use spintronics for data storage, focusing on low bit density applications such as tamper prevention and detection [S1].
• NVE manufactures products in-house including wafer fabrication and product testing, with a certified facility under ISO 9001:2015 and ECS/CIG 021-024:2014 standards [S1].
• Sales are conducted through distributors in over 75 countries and private-brand partnerships with large integrated device manufacturers [S1].
• The company holds over 50 issued U.S. patents and additional foreign patents, including patents on advanced MRAM designs [S1].
• NVE relies on several large customers including Abbott Laboratories and distributors for a significant portion of revenue [S1].
• The company is subject to various government regulations including environmental, tax, securities, import/export controls, and workplace safety [S1].
• As of March 31, 2026, NVE had 42 employees, with a workforce demographic showing 74% male and 26% female, and 33% from underrepresented groups [S1].
• Employee turnover was 7% in fiscal 2026, below the semiconductor industry average [S1].
• Financial snapshot as of September 30, 2026: cash and equivalents $3.97 million, short-term investments $19.68 million, current assets $35.06 million, current liabilities $1.21 million, current ratio 29.05, cash ratio 19.6 [S2].
• Revenue for Q1 2027 (ended June 30, 2026) was $11.03 million; net income for Q2 2027 (ended September 30, 2026) was $3.17 million [S2].
• Basic EPS for Q2 2027 was $0.66 and diluted EPS was $0.65 [S2].
• Recent news highlights include a year-over-year surge in Q1 earnings driven by strong sales and new products, solid earnings growth in Q4, and an 'Outperform' rating based on defense recovery and AIoT demand [N1][N4][N5].
• Earnings call transcripts and highlights provide insights into growth momentum and product developments [N2][N3][N6][N7][N8].